190 related articles for article (PubMed ID: 35978257)
21. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease.
Cazzola M; Bettoncelli G; Sessa E; Cricelli C; Biscione G
Respiration; 2010; 80(2):112-9. PubMed ID: 20134148
[TBL] [Abstract][Full Text] [Related]
22. Chronic obstructive pulmonary disease and comorbidities' influence on mortality in non-small cell lung cancer patients.
Media AS; Persson M; Tajhizi N; Weinreich UM
Acta Oncol; 2019 Aug; 58(8):1102-1106. PubMed ID: 31092081
[No Abstract] [Full Text] [Related]
23. Existing comorbidities in people with osteoarthritis: a retrospective analysis of a population-based cohort in Alberta, Canada.
Marshall DA; Liu X; Barnabe C; Yee K; Faris PD; Barber C; Mosher D; Noseworthy T; Werle J; Lix L
BMJ Open; 2019 Nov; 9(11):e033334. PubMed ID: 31753902
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis.
Rotstein D; Maxwell C; Tu K; Gatley J; Pequeno P; Kopp A; Marrie RA
Mult Scler; 2021 Oct; 27(12):1902-1913. PubMed ID: 34328821
[TBL] [Abstract][Full Text] [Related]
25. A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.
Hauer L; Perneczky J; Sellner J
J Neurol; 2021 Nov; 268(11):4066-4077. PubMed ID: 32719975
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population.
Anecchino C; Rossi E; Fanizza C; De Rosa M; Tognoni G; Romero M;
Int J Chron Obstruct Pulmon Dis; 2007; 2(4):567-74. PubMed ID: 18268930
[TBL] [Abstract][Full Text] [Related]
27. Comorbidity Patterns in Patients Newly Diagnosed With Colorectal Cancer: Network-Based Study.
Qiu H; Wang L; Zhou L; Wang X
JMIR Public Health Surveill; 2023 Sep; 9():e41999. PubMed ID: 37669093
[TBL] [Abstract][Full Text] [Related]
28. Atherosclerosis and multiple sclerosis: An overview on the prevalence of risk factors.
Etemadifar M; Salari M; Esnaashari A; Ghazanfaripoor F; Sayahi F; Akhavan Sigari A; Sedaghat N
Mult Scler Relat Disord; 2022 Feb; 58():103488. PubMed ID: 34999375
[TBL] [Abstract][Full Text] [Related]
29. Multiple sclerosis incidence in Tuscany from administrative data.
Bezzini D; Policardo L; Profili F; Meucci G; Ulivelli M; Bartalini S; Francesconi P; Battaglia MA
Neurol Sci; 2018 Nov; 39(11):1881-1885. PubMed ID: 30090983
[TBL] [Abstract][Full Text] [Related]
30. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of diabetes and cardiovascular comorbidity in the Canadian Community Health Survey 2002-2003.
Mo F; Pogany LM; Li FC; Morrison H
ScientificWorldJournal; 2006 Jan; 6():96-105. PubMed ID: 16435038
[TBL] [Abstract][Full Text] [Related]
32. Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course.
Conway DS; Thompson NR; Cohen JA
Mult Scler; 2017 Feb; 23(2):277-285. PubMed ID: 27230791
[TBL] [Abstract][Full Text] [Related]
33. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
[TBL] [Abstract][Full Text] [Related]
34. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.
Panopoulos S; Thomas K; Georgiopoulos G; Boumpas D; Katsiari C; Bertsias G; Drosos AA; Boki K; Dimitroulas T; Garyfallos A; Papagoras C; Katsimbri P; Tziortziotis A; Adamichou C; Kaltsonoudis E; Argyriou E; Vosvotekas G; Sfikakis PP; Vassilopoulos D; Tektonidou MG
Rheumatology (Oxford); 2021 Jan; 60(1):170-178. PubMed ID: 32596727
[TBL] [Abstract][Full Text] [Related]
35. Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey.
Griffo R; Spanevello A; Temporelli PL; Faggiano P; Carone M; Magni G; Ambrosino N; Tavazzi L;
Eur J Prev Cardiol; 2017 Apr; 24(6):567-576. PubMed ID: 28067533
[TBL] [Abstract][Full Text] [Related]
36. The economic impact of comorbidity in multiple sclerosis.
Ponzio M; Monti MC; Mallucci G; Borrelli P; Fusco S; Tacchino A; Brichetto G; Tronconi L; Montomoli C; Bergamaschi R
Neurol Sci; 2023 Mar; 44(3):999-1008. PubMed ID: 36441342
[TBL] [Abstract][Full Text] [Related]
37. Comorbidity, socioeconomic status and multiple sclerosis.
Marrie R; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
Mult Scler; 2008 Sep; 14(8):1091-8. PubMed ID: 18728060
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and clustering of chronic diseases in Tuscany (Central Italy): evidence from a large administrative data warehouse.
Profili F; Maciocco G; Bellini B; Razzanelli M; Francesconi P
Epidemiol Prev; 2020; 44(5-6):385-393. PubMed ID: 33706491
[TBL] [Abstract][Full Text] [Related]
39. Comparing the risk of serious infections in patients with and without MS: A German claims data analysis.
Knapp R; Hardtstock F; Wilke T; Maywald U; Chognot C; Craveiro L; Rouzic EM
Mult Scler Relat Disord; 2023 Apr; 72():104583. PubMed ID: 36905817
[TBL] [Abstract][Full Text] [Related]
40. Ascertainment of chronic diseases using population health data: a comparison of health administrative data and patient self-report.
Muggah E; Graves E; Bennett C; Manuel DG
BMC Public Health; 2013 Jan; 13():16. PubMed ID: 23302258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
